Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is 13.40.

Share Price ₹110.3Sep 13,2024
Market Cap ₹608.7 Cr
Earnings-TTM₹45.4 CrTTM-Consolidated Results
Price/Earnings13.40xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹608.7 Cr] as on Sep 13,2024

(/) Earnings [ ₹45.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 13.40x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 13.40 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 13.40x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.11x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS 45.4413.40608.7
ADANI ENTERPRISES LTD4,226.9880.06338,421.0
REDINGTON LTD1,200.4512.4314,920.2
HONASA CONSUMER LTD126.07127.1416,028.4
MMTC LTD96.91147.2814,272.5
MSTC LTD222.5123.295,182.1
LLOYDS ENTERPRISES LTD176.7929.875,280.6
VERITAS (INDIA) LTD209.7912.252,570.1
NOVARTIS INDIA LTD90.6729.222,649.8
OPTIEMUS INFRACOM LTD57.4697.565,605.6
MISHTANN FOODS LTD11.11146.021,622.9

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 12.25x
Max industry PE 147.28x
Median industry PE 29.87x
Average industry PE 65.32x



You may also like the below Video Courses